27618734|t|Mucosal and cutaneous human papillomaviruses in head and neck squamous cell papillomas
27618734|a|Conflicting data exist regarding the contribution of human papillomavirus (HPV) to the development of head and neck squamous cell papillomas. Formalin-fixed paraffin-embedded papillomas were tested for 28 mucosal and 79 cutaneous HPVs using polymerase chain reaction (PCR)-based methods. Eighty-three papillomas (43 oropharyngeal, 31 oral, 6 laryngeal, and 3 nasopharyngeal) were analyzed. Twenty-four samples (28.9%) harbored mucosal HPVs: 3 oropharyngeal (6.9%), 15 oral (48.3%), 4 laryngeal (66.7%), and 2 nasopharyngeal papillomas (66.7%). Eighty-one cases were also tested for cutaneous HPVs, detected in 16 lesions (19.7%): 11 (13.5%) harbored only cutaneous types, and 5 (6.2%) were positive for both cutaneous and mucosal HPVs. Among these 81 cases, prevalence of mucosal and/or cutaneous HPV infection was 43.2%. HPV DNA detection in a fraction of head and neck papillomas supports the role of HPV in their development. However, other markers need to be considered to confirm the association of HPV infection with these lesions. Â© 2016 Wiley Periodicals, Inc. Head Neck 39: 254-259, 2017.
27618734	0	7	Mucosal	T024	C0026724
27618734	12	21	cutaneous	T082	C0221912
27618734	22	44	human papillomaviruses	T005	C0021344
27618734	48	52	head	T029	C0018670
27618734	57	61	neck	T029	C0027530
27618734	62	86	squamous cell papillomas	T191	C0205874
27618734	87	98	Conflicting	T080	C1705242
27618734	99	103	data	T078	C1511726
27618734	104	109	exist	T077	C2987476
27618734	124	136	contribution	T052	C1880177
27618734	140	160	human papillomavirus	T005	C0021344
27618734	162	165	HPV	T005	C0021344
27618734	174	185	development	T169	C1527148
27618734	189	193	head	T029	C0018670
27618734	198	202	neck	T029	C0027530
27618734	203	227	squamous cell papillomas	T191	C0205874
27618734	229	272	Formalin-fixed paraffin-embedded papillomas	T191	C0030354
27618734	278	284	tested	T169	C0039593
27618734	292	299	mucosal	T024	C0026724
27618734	307	316	cutaneous	T082	C0221912
27618734	317	321	HPVs	T005	C0021344
27618734	328	373	polymerase chain reaction (PCR)-based methods	T063	C0032520
27618734	375	387	Eighty-three	T081	C0392762
27618734	388	398	papillomas	T191	C0030354
27618734	403	416	oropharyngeal	T029	C0521367
27618734	421	425	oral	T030	C0226896
27618734	429	438	laryngeal	T023	C0023078
27618734	446	460	nasopharyngeal	T023	C0027442
27618734	467	475	analyzed	T062	C0936012
27618734	477	488	Twenty-four	T081	C0392762
27618734	489	496	samples	T077	C2347026
27618734	505	513	harbored	T080	C0205556
27618734	514	521	mucosal	T024	C0026724
27618734	522	526	HPVs	T005	C0021344
27618734	530	543	oropharyngeal	T029	C0521367
27618734	555	559	oral	T030	C0226896
27618734	571	580	laryngeal	T023	C0023078
27618734	596	610	nasopharyngeal	T023	C0027442
27618734	611	621	papillomas	T191	C0030354
27618734	631	641	Eighty-one	T081	C0392762
27618734	642	647	cases	T077	C1706256
27618734	658	664	tested	T169	C0039593
27618734	669	678	cutaneous	T082	C0221912
27618734	679	683	HPVs	T005	C0021344
27618734	685	693	detected	T033	C0442726
27618734	700	707	lesions	T033	C0221198
27618734	728	736	harbored	T080	C0205556
27618734	742	751	cutaneous	T082	C0221912
27618734	752	757	types	T080	C0332307
27618734	777	785	positive	T033	C1446409
27618734	795	804	cutaneous	T082	C0221912
27618734	809	816	mucosal	T024	C0026724
27618734	817	821	HPVs	T005	C0021344
27618734	838	843	cases	T077	C1706256
27618734	845	855	prevalence	T081	C0033105
27618734	859	866	mucosal	T024	C0026724
27618734	874	883	cutaneous	T082	C0221912
27618734	884	897	HPV infection	T047	C0343641
27618734	909	926	HPV DNA detection	T059	C0201678
27618734	932	943	fraction of	T081	C1264633
27618734	944	948	head	T029	C0018670
27618734	953	957	neck	T029	C0027530
27618734	958	968	papillomas	T191	C0030354
27618734	969	977	supports	T080	C0205556
27618734	990	993	HPV	T005	C0021344
27618734	1003	1014	development	T169	C1527148
27618734	1025	1038	other markers	T025	C1955343
27618734	1050	1060	considered	T078	C1511726
27618734	1064	1071	confirm	T080	C1456348
27618734	1076	1087	association	T080	C0439849
27618734	1091	1104	HPV infection	T047	C0343641
27618734	1116	1123	lesions	T033	C0221198